Reframing the Language Classroom through Discovery-Based Frameworks
L2 Journal · 2024
DOI: 10.5070/l2.24861 ↗Kurz gefasst
Fachartikel in der Zeitschrift L2 Journal, 2024. Verfasst von Rabindra Hayashi und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The past four years have seen radical upheaval in language pedagogy due to restrictions imposed by the outbreak of COVID-19 and the advent of generative AI. Increasing evidence that remote learning options can be just as effective as in-person ones has additionally forced educators to re-evaluate and re-articulate the methods and purpose of in-person classroom instruction. This report suggests that a discovery-based framework can help transform classrooms into spaces in which students go beyond simple skill acquisition to become a community of learners through an increased focus on first-hand experiences. These experiences furthermore promote curiosity and ownership over projects in the target language, extending learning beyond the confines of the classroom. With discussion of a successful example conducted in Korean language classes, the article explores how discovery-based frameworks reinforce acquisition of the target language as a tool for cultivating students’ relationships with a broader community of speakers in a personally meaningful way. This report therefore underscores the efficacy, ethicality, and endurance of discovery-based frameworks in classroom instruction as a holistic pedagogical approach.
Zitieren
APA
Hayashi, R., & Kim, M. (2024). Reframing the Language Classroom through Discovery-Based Frameworks. L2 Journal. https://doi.org/10.5070/l2.24861
Vancouver
Hayashi R, Kim M. Reframing the Language Classroom through Discovery-Based Frameworks. L2 Journal. 2024. doi:10.5070/l2.24861
BibTeX
@article{Hayashi2024,
author = {Hayashi, Rabindra and Kim, Minsook},
title = {Reframing the Language Classroom through Discovery-Based Frameworks},
journal = {L2 Journal},
year = {2024},
doi = {10.5070/l2.24861}
}
EUVIMED